Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 2:51 AM
Ignite Modification Date: 2025-12-25 @ 2:51 AM
NCT ID: NCT07136233
Eligibility Criteria: Inclusion Criteria: * Households who qualify for automatic renewal of their Covered California health plan as of October 4. * Households that were enrolled in Covered California on the subsidized application. Exclusion Criteria: Households that were no longer enrolled as of January 31, 2025. This includes people who chose to cancel their coverage in 2024 and those who were automatically disenrolled due to changes in eligibility during the open enrollment period.) * Households that were included in the affordability crosswalk 1. The affordability crosswalk is a Covered California process that moves eligible individuals with lower incomes to Silver CSR plans during renewal. 2. This population includes members with incomes below 250% of the federal poverty level who were enrolled in Bronze plans and eligible for $0 premiums with Silver plans, members below 200% of the federal poverty level who were enrolled in Gold plans, and members below 150% of the federal poverty level who were enrolled in Platinum plans. 3. Approximately 23,000 members are excluded from the experiment due to this restriction. * Households with members enrolled with the carrier Valley Health Plan and Dental Health Services. 1. This group was excluded due to changes in plan availability that necessitated a special notice. 2. Approximately 30,000 members are excluded from this experiment due to this restriction.
Healthy Volunteers: True
Sex: ALL
Study: NCT07136233
Study Brief:
Protocol Section: NCT07136233